Latest News

Date Title Topic
22 May 2015 WHO Model List of Essential Medicines Revised Bioethics, legal and economic issues - Anticancer agents & Biologic therapy
20 May 2015 Pembrolizumab Seems to be a New Immune Checkpoint Inhibitor Option for NSCLC, However is our Knowledge on Tumour Biomarkers Enough? Lung and other thoracic tumours
18 May 2015 Annals of Oncology Press Release: World First – Researchers Quantify the Proportion of Different Genetic Mutations Contained within Individual Bowel Cancers Gastrointestinal cancers
15 May 2015 Results of a study presented at the ESMO World Congress on Gastrointestinal Cancer 2014 and the ESMO Congress 2014 published in The New England Jour...
12 May 2015 Lower Radiation Doses May Be Sufficient For Treating Certain Cancers, Report IAEA Experts Bioethics, legal and economic issues
08 May 2015 IMPAKT 2015 News: Molecular Screening of Patients with Metastatic Breast Cancer Can Be Carried-Out Across EU Countries Breast cancer - Personalised medicine
07 May 2015 IMPAKT 2015 News: Constitutively Activated STAT3 May Be a Predictive Marker for Resistance to Trastuzumab in Patients with HER2 Positive Breast Cancer Breast cancer - Translational research - Anticancer agents & Biologic therapy
07 May 2015 IMPAKT 2015 News: A Circulating Tumour Cell Liquid Biopsy May Be Used for Non-Invasive Mutational Analysis in Patients with Breast Cancer Breast cancer - Translational research
07 May 2015 IMPAKT 2015 News: PI3 Kinase and CDK4/6 Inhibitors Are Highly Active in ER-Positive Breast Cancer Breast cancer - Translational research - Anticancer agents & Biologic therapy
07 May 2015 IMPAKT 2015 News: Gene Expression Signatures May Signal Clinical Activity of Palbociclib in Patients with Breast Cancer Breast cancer - Translational research - Anticancer agents & Biologic therapy
05 May 2015 Survey: The role of precision medicine in “Real Life” management of breast cancer patients
Programme
28 Apr 2015 European Medicine Agency Recommends Refusal of the Marketing Authorisation for Dasiprotimut-T Haematologic malignancies - Immuno-oncology
27 Apr 2015 FDA Approves Ramucirumab for Metastatic Colorectal Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
24 Apr 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Nivolumab Melanoma - Immuno-oncology